Translating chronic kidney disease epidemiology into patient care-the individual/public health risk paradox

Nephrology Dialysis Transplantation

Volumn 27, Issue SUPPL. 3, 2012, Pages

  Marks, Angharad ^a,b   Black, Corri ^a,b   Fluck, Nicholas ^b   Smith, William Cairns S ^a,b   Prescott, Gordon J ^a   Clark, Laura E ^c   Ali, Tariq Z ^d   Simpson, William G ^b   MacLeod, Alison M ^a,b  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b NHS GRAMPIAN   (United Kingdom)

^c NHS FIFE   (United Kingdom)

^d EAST KENT HOSPITALS UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

chronic kidney disease; epidemiology and outcomes; mortality; renal progression; risk communication

Indexed keywords

ALBUMIN;

ADOLESCENT; ADULT; AGED; AGING; ARTICLE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; DISEASE SEVERITY; EXPLORATORY RESEARCH; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEALTH CARE PLANNING; HEALTH HAZARD; HUMAN; INCIDENTAL FINDING; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PATIENT CARE; POPULATION RESEARCH; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RENAL REPLACEMENT THERAPY; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; GREAT BRITAIN; HEALTH PLANNING; HUMANS; MALE; MIDDLE AGED; PATIENT CARE; PROGNOSIS; PUBLIC HEALTH; RENAL INSUFFICIENCY, CHRONIC; RENAL REPLACEMENT THERAPY; RISK FACTORS; SURVIVAL RATE; YOUNG ADULT;

EID: 84868545921     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr746     Document Type: Article

References (30)

1. National Kidney Foundation. KDOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 2002; 39 (Suppl 1): S1.
2. National Institute for Health and Clinical Excellence. Chronic Kidney Disease: National Clinical Guideline for Early Identification and Management in Adults in Primary and Secondary Care. London, UK: Royal College of Physicians, 2008.
3. Scottish Intercollegiate Guidelines Network. Diagnosis and Management of Chronic Kidney Disease: A National Clinical Guideline. Edinburgh, UK: Scottish Intercollegiate Guidelines Network, 2008. Report No.: 103.
4. Black C, Sharma P, Scotland G et al. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis. Health Technol Assess 2010; 14: 1-184.
5. Hallan SI, Dahl K, Oien CM et al. Screening strategies for chronic kidney disease in the general population: follow-up of cross sectional health survey. BMJ 2006; 333: 1047-1050.
6. Hemmelgarn BR, Manns BJ, Lloyd A et al. Relation between kidney function, proteinuria, and adverse outcomes. JAMA 2010; 303: 423-429.
7. Astor BC, Hallan SI, Miller ER et al. Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population. Am J Epidemiol 2008; 167: 1226-1234.
8. Levin A, Djurdjev O, Beaulieu M et al. Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort. Am J Kidney Dis 2008; 52: 661-671.
9. Glassock RJ, Winearls C. Diagnosing chronic kidney disease. Curr Opin Nephrol Hypertens 2010; 19: 123-128.
10. Ali T, Khan I, Simpson W et al. Incidence and outcomes in acute kidney injury: a comprehensive population-based study. J Am Soc Nephrol 2007; 18: 1292-1298.
11. Clark L. The Epidemiology of Chronic Kidney Disease in Grampian. Dissertation. Aberdeen, UK: University of Aberdeen 2009.
12. General Register Office for Scotland. Deaths by Post-April 2006 NHS Board Area, by Age Group and Sex, 1997 to 2009. http://www.gro-scotland.gov.uk/ statistics/theme/vital-events/deaths/timeseries. html (28 March 2011, date last accessed).
13. General Register Office for Scotland. source Mid-Year Population Estimates; Scotland and its NHS Board Areas by Single Year of Age and Sex: 1981-2009. Population Estimates Time Series Data. http://www.gro-scotland.gov. uk/statistics/theme/population/estimates/mid-year/time-series.html (28 March 2011, date last accessed).
14. Eriksen BO, Ingebretsen OC. The progression of chronic kidney disease: a 10-year population-based study of the effects of gender and age. Kidney Int 2006; 69: 375-382.
15. Hallan SI, Stevens P. Screening for chronic kidney disease: which strategy?. J Nephrol 2010; 23: 147-155.
16. Levey AS, Gansevoort RT, Matsushita K et al. Grouping eGFR and albuminuria stages into "risk categories" for CKD clinical practice guidelines: summary of initial results for the CKD prognosis consortium. Renal Week 2010 Abstracts, American Society of Nephrology. 2010 16-21 November: A48-A49.
17. Conway B, Webster A, Ramsay G et al. Predicting mortality and uptake of renal replacement therapy in patients with stage 4 chronic kidney disease. Nephrol Dial Transplant 2009; 24: 1930-1937.
18. Raymond NT, Zehnder D, Smith SC et al. Elevated relative mortality risk with mild-to-moderate chronic kidney disease decreases with age. Nephrol Dial Transplant 2007; 22: 3214-3220.
19. Roderick PJ, Atkins RJ, Smeeth L et al. CKD and mortality risk in older people: a community-based population study in the United Kingdom. Am J Kidney Dis 2009; 53: 950-960.
20. Johnson ES, Thorp ML, Yang X et al. Predicting renal replacement therapy and mortality in CKD. Am J Kidney Dis 2007; 50: 559-565.
21. Hallan S, Ritz E, Lydersen S et al. Combining GFR and albuminuria to classify CKD improves prediction of ESRD. J Am Soc Nephrol 2009; 20: 1069-1077.
22. Hallan S, Astor B, Romundstad S et al. Association of kidney function and albuminuria with cardiovascular mortality in older vs younger individuals: the HUNT II study. Arch Intern Med 2007; 167: 2490-2496.
23. Byrne C, Ford D, Gilg J et al. UK Renal Registry 12th Annual Report (December 2009): chapter 3: UK ESRD incident rates in 2008: national and centre-specific analyses. Nephron Clin Pract 2010; 115: c9-c40.
24. Coresh J, Selvin E, Stevens L et al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038-2047.
25. Stevens PE, O'Donoghue DJ, de Lusignan S et al. Chronic kidney disease management in the United Kingdom: NEOERICA project results. Kidney Int 2007; 72: 92-99.
26. O'Hare AM, Bertenthal D, Covinsky KE et al. Mortality risk stratification in chronic kidney disease: one size for all ages?. J Am Soc Nephrol 2006; 17: 846-853.
27. Campbell KH, O'Hare AM. Kidney disease in the elderly: update on recent literature. Curr Opin Nephrol Hypertens 2008; 17: 298-303.
28. Foster MC, Hwang S, Larson MG et al. Cross-classification of microalbuminuria and reduced glomerular filtration rate: associations between cardiovascular disease risk factors and clinical outcomes. Arch Intern Med 2007; 167: 1386-1392.
29. Irie F, Iso H, Sairenchi T et al. The relationships of proteinuria, serum creatinine, glomerular filtration rate with cardiovascular disease mortality in Japanese general population. Kidney Int 2006; 69: 1264-1271.
30. Matsushita K, van der Velde M et al. Chronic Kidney Disease Prognosis Consortium (CKD-PC). Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010; 375: 2073-2081.